About MedKoo

MedKoo, DBA name-MedKoo Biosciences, is a world leading reagent supplier, specializing small molecule research-use medicines (i.e. non-human-use drugs). Our products include (1) drugs that were approved, are in clinical trials and pre-clinical trials; (2) kinase inhibitors, tool molecules, probes, imaging agents; (3) bioactive small molecules which were previously reported in peer-reviewed research publications; (4) linkers for bioconjugate synthesis, drug delivery and antibody-drug conjugation (ADC) ; (5) Biochemicals and other pharmaceutical related chemicals. Our headquarter is located in Research Triangle Park, North Carolina, USA. We have research and manufacturing facilities in both China and USA with capability to synthesize complicated drugs.


MedKoo was founded in 2009 by Dr. Qingqi Chen, who obtained a Ph.D. in synthetic chemistry from Peking University, and received postdoctoral trainings at Johannes-Kepler University Linz (with Dr. Heinz Falk), University of Nevada Reno (with Dr. David Lightner), and University of British Columbia (with Dr. David Dolphin). Dr. Chen is currently the President and CEO of MedKoo. Prior to joining MedKoo, Dr. Chen was a distinguished professor at the School of Pharmaceutical Sciences of Zhongshan University (Sun Yat-sen University, Guangzhou, China) and a distinguished professor at the Chinese Academy of Sciences (Beijing, China). Dr. Chen also held senior positions in several pharmaceutical companies in USA, where he made contributions to the R&D of several FDA approved drugs. Dr. Chen has a strong interest in small molecule anticancer drug discovery and has published over 100 papers, submitted over 20 patent applications, and authorized or co-authorized 11 books, which were related to new drug discovery, drug synthesis and drug patent.


MedKoo currently has over 10000 inventory products with potential capacity to supply over 50000 small molecule drugs for life-science research use and laboratory tests. We are well educated and extensively-trained synthetic chemists with remarkable expertise on drug synthesis. Currently we have capability to make over 400 new drugs per year. Each product, each batch will be analyzed by NMR, HPLC and MS. Quality is 100% guaranteed. As always, we are supplying products having highest quality and most competitive prices. MedKoo will do price match if customers obtained better price from other USA-based vendors. 

Our web pages are extensively being updated on daily-basis with respect to the number of new products and prices. We encourage customers to search our web page for price and availability. If product is in stock, price and shipping out time are listed. If no price is listed, this means the product is not in stock, which may be available by custom synthesis (usually expensive).


Our success is due to our competitive pricing, our firmly commitment to customer service and to the talent and experience of our scientists, most of whom hold doctorates in chemistry, pharmaceuticals and chemical engineers.


Research services: including all areas of medicinal chemistry research, custom organic synthesis, synthetic route optimization, synthetic process development, formulation development, bioanalytical services, molecule sourcing services, and molecule distributing services.


MedKoo was originated from the combination of two words: “Medicine” and “Koo”. In Chinese, “Koo” means big stockroom or warehouse. MedKoo literally means a comprehensive collection of medicinal chemicals.